Convergence Financial, LLC Merck & Co., Inc. Transaction History
Convergence Financial, LLC
- $471 Billion
- Q3 2024
A detailed history of Convergence Financial, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Convergence Financial, LLC holds 8,689 shares of MRK stock, worth $875,242. This represents 0.21% of its overall portfolio holdings.
Number of Shares
8,689
Previous 9,362
7.19%
Holding current value
$875,242
Previous $1.16 Billion
14.87%
% of portfolio
0.21%
Previous 0.31%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,807Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$24.6 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$11.8 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.3 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$5.74 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $255B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...